Analytical Data
-
Gene name
NAA38
- Application
-
Alternative Names
LSM domain-containing protein 1;Phosphonoformate immuno-associated protein 2
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BRA0
-
Expression Region
2-173aa
-
Molecular Weight
34.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NAA38, or N-acetyltransferase 38, is a member of the N-terminal acetyltransferase family, which plays a crucial role in the post-translational modification of proteins through N-terminal acetylation. This modification is vital for protein stability, cellular localization, and interaction with other biomolecules, thereby influencing various cellular processes. Recent studies suggest that NAA38 may have important implications in various biological functions and diseases, including cancer and neurodegenerative disorders. Understanding the structure and function of NAA38 can provide insights into its biological roles and potential therapeutic targets. The recombinant production of NAA38 not only facilitates detailed biochemical characterization but also allows for the exploration of its enzymatic activity and substrate specificity. This research aims to elucidate the molecular mechanisms by which NAA38 influences protein function and to assess its potential as a biomarker or target for drug development. By leveraging recombinant protein technology, scientists can create a platform for high-throughput screening of inhibitors or modulators of NAA38, which may ultimately lead to novel therapeutic strategies in diseases where acetylation processes are disrupted.
